Cargando…
The Impact of the Initial Phase of the COVID-19 Pandemic on Patients With Autoimmune Bullous Diseases
Introduction The follow-up of patients with autoimmune bullous diseases (AIBDs) was temporarily interrupted during the initial phase of the COVID-19 pandemic due to restrictions in healthcare services, given the high contagiousness and rapid spread of SARS-CoV-2. Our objective was to assess the impa...
Autores principales: | Örnek, Sinem, Erdem, Betul, Gönül, Müzeyyen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585190/ https://www.ncbi.nlm.nih.gov/pubmed/37868380 http://dx.doi.org/10.7759/cureus.45545 |
Ejemplares similares
-
Autoimmune Bullous Dermatosis Following COVID-19 Vaccination: A Series of Five Cases
por: Hali, Fouzia, et al.
Publicado: (2022) -
The Autoimmune Bullous Diseases
por: Wakelin, S H, et al.
Publicado: (1997) -
Utility of Direct Immunofluorescence in Cutaneous Autoimmune Bullous Disorders
por: Brar, Arika, et al.
Publicado: (2021) -
Bullous Pilomatrixoma After COVID-19 Vaccination
por: Alvarez-Rubio, Francisco Javier, et al.
Publicado: (2022) -
Dyshidrosiform Bullous Pemphigoid Triggered by COVID-19 Vaccination
por: Shanshal, Mohammed
Publicado: (2022)